BLID is a drug-responsive target of FOXO3a and multi-omics analysis reveals survival mechanisms and therapeutic vulnerabilities in BLID-deficient breast cancer cells
Sivaramakrishna Yadavalli(Georgetown University), Usha N. Kasid(Georgetown University Medical Center)
Cited by 0
Related Papers
TMEM33: a new stress-inducible endoplasmic reticulum transmembrane protein and modulator of the unfolded protein response signaling
|Breast Cancer Research and Treatment|2015|41